Gene · 6573
Papers1,999
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,999
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of solute carrier family 19 member 1 (SLC19A1) A80G polymorphism with the maternal risk for having a child with Down syndrome: A systematic review and meta-analysis. | Mutat Res Rev Mutat Res | 2026 | 42762765 | PubTator, text mining | PubMed |
| Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study. | Front Pharmacol | 2026 | 42548792 | PubTator, text mining | PubMed |
| Immunometabolic Stratification of Autism Spectrum Disorder by CD4+ T-Cell Phenotype Reveals Subtype-Specific Energetic Deficit and Coordinated Suppression of Micronutrient Acquisition Pathways. | Metabolites | 2026 | 42346396 | PubTator, text mining | PubMed |
| Functional genomics and proteomics identify Folate Carrier SLC19A1 as a predictor of pralatrexate sensitivity in diverse T-cell lymphoma models. | Mol Cancer Ther | 2026 | 42295240 | PubTator, text mining | PubMed |
| High folate receptor expression is associated with aggressive features in prostate cancer with low prostate-specific membrane antigen expression. | BJUI Compass | 2026 | 42255325 | PubTator, text mining | PubMed |
| Dissecting the role of PCNA and Pif1 in replication of individual DNA molecules by DNA polymerase δ. | bioRxiv | 2026 | 42239345 | PubTator, text mining | PubMed |
| Association of Variants in Candidate Pharmacogenes with Response to Mercaptopurine and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Single-Center Experience from Croatia. | Oncol Ther | 2026 | 42168754 | PubTator, text mining | PubMed |
| Extracellular cGAMP in health and disease. | Mol Biomed | 2026 | 42106567 | PubTator, text mining | PubMed |
| Early Erythrocyte Methotrexate Polyglutamate-4 Predicts Treatment Response and Is Influenced by GGH 401C>T Genotype in Patients with Rheumatoid Arthritis. | Arch Rheumatol | 2026 | 41989453 | PubTator, text mining | PubMed |
| Advances in methotrexate nano-formulations to enhance therapeutic efficacy against drug-resistant breast cancer. | Discov Nano | 2026 | 41925980 | PubTator, text mining | PubMed |
| Folate Receptor Alpha (FRα) and the Developing Brain: From Molecular Function to Neurodevelopmental Outcomes. | Mol Neurobiol | 2026 | 41882276 | PubTator, text mining | PubMed |
| The cGAS-STING pathway in cancer: friend or foe. | Cell Death Dis | 2026 | 41881950 | PubTator, text mining | PubMed |
| Monocytes from inflammatory arthritis patients accumulate methotrexate and their transcriptome predicts methotrexate clinical response. | Cell Mol Life Sci | 2026 | 41840229 | PubTator, text mining | PubMed |
| Folate promotes colorectal cancer progression by impairing CD8+ T cell function and recruitment via SLC19A1/p-AKT/NOTCH1 axis and CCL5 downregulation. | J Transl Med | 2026 | 41827010 | PubTator, text mining | PubMed |
| Prostate‑specific membrane antigen: Molecular functions and emerging roles as a therapeutic target (Review). | Mol Med Rep | 2026 | 41789574 | PubTator, text mining | PubMed |
| Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion. | Proc Natl Acad Sci U S A | 2026 | 41770933 | PubTator, text mining | PubMed |
| CT Radiogenomics Provides a Novel Factor for cM0(i+) Risk Stratification in Localized Renal Cell Carcinoma: A Model Linked to a Circulating Tumor Cell-Related Gene Signature. | Acad Radiol | 2026 | 41765704 | PubTator, text mining | PubMed |
| Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes: Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia. | Pharmaceuticals (Basel) | 2026 | 41754808 | PubTator, text mining | PubMed |
| Unusual Micronutrient Deficiencies as Causes of Anemia. | Nutrients | 2026 | 41754181 | PubTator, text mining | PubMed |
| Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy. | Innovation (Camb) | 2026 | 41737316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6573/papers